Bruce Bodaken - Rite Aid Independent Chairman of the Board

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Fiscal Quarter End: 31st of May 2020  

Mr. Bruce G. Bodaken serves as Chairman of the Board of the Company effective Oct. 30, 2018. From 2000 through December 2012, Mr. Bodaken served as Chairman and Chief Executive Officer of Blue Shield of California. Mr. Bodaken also previously served as President and Chief Operating Officer of Blue Shield of California from 1995 to 2000 and Executive Vice President and Chief Operating Officer from 1994 to 1995. Prior to joining Blue Shield of California, Mr. Bodaken served as Senior Vice President and Associate Chief Operating Officer of F.H.P., Inc., a managed care provider, from 1990 to 1994 and held various positions at F.H.P. from 1980 to 1990, including Regional Vice President. Mr. Bodaken is currently a director and a member of the audit committee of WageWorks, Inc. He also has a Visiting Scholar appointment at the Brookings Institution and is a Visiting Lecturer in the Department of Public Health at UC Berkeley.
Age: 66  Chairman Since 2018      
717 975-5905

Bruce Bodaken Latest Insider Activity

Rite Aid Management Efficiency

Rite Aid has Return on Asset of (0.0545) % which means that on every $100 spent on asset it lost $0.0545. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (49.8677) % meaning that it generated no profit with money invested by stockholders. Rite Aid management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The last year's Return on Invested Capital was at 0.07. The current year Return on Sales is expected to grow to 0.030103, whereas Return on Average Assets are expected to grow to (0.05) . Rite Aid Current Assets are expected to significantly decrease based on the last few years of reporting. The last year's Current Assets were at 3.7 Billion. The current year Goodwill and Intangible Assets is expected to grow to about 665.6 M, whereas Tax Assets are expected to decline to about 1.4 B. Rite Aid Current Liabilities is expected to significantly increase based on the last few years of reporting. The last year's Current Liabilities was at 2.77 Billion. The current year Tax Liabilities is expected to grow to about 73.7 M, whereas Liabilities Non Current is expected to decline to about 5.5 B.
The company has 7.12 B in debt with debt to equity (D/E) ratio of 740.8 . This implies that the company may be unable to create cash to meet all of its financial commitments. Rite Aid has Current Ratio of 1.5 which is typical for the industry and considered as normal.

Similar Executives

Found 13 records


Thomas BeneSysco
Xiaobo HongVipshop Holdings Limited
Jacquelyn WardSysco
Roxanne AustinTarget
Edward ShirleySysco
Robert McMasterSally Beauty Holdings
Gary WinterhalterSally Beauty Holdings
Douglas SandersSprouts Farmers Market
Omar AsaliSpectrum Brands Holdings
David MauraSpectrum Brands Holdings
Brian CornellTarget
David CFASpectrum Brands Holdings
Eric ShenVipshop Holdings Limited

Company Summary

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people.

Rite Aid Leadership Team

Heyward Donigan, President, Chief Executive Officer, Director
Joseph Anderson, Independent Director
Elizabeth Burr, Independent Director
Douglas Donley, Chief Accounting Officer, Senior Vice President
Jim Peters, Chief Operating Officer
Michael Regan, Lead Independent Director
Arun Nayar, Independent Director
Brian Hoover, Chief Accounting Officer
David Jessick, Independent Director
Katherine Quinn, Independent Director
Myrtle Potter, Director
Bruce Bodaken, Independent Chairman of the Board
Kevin Lofton, Independent Director
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer
David Abelman, Executive Vice President - Marketing
Frank Savage, Independent Director
Kermit Crawford, President COO
Marcy Syms, Independent Director
James Comitale, Senior Vice President General Counsel, Secretary
Steve Rempel, Senior Vice President CIO
Justin Mennen, Senior Vice President, Chief Information Officer
Dedra Castle, Chief Human Resource Officer, Executive Vice President
Erik Keptner, Senior Vice President Chief Marketing Officer
Marc Strassler, Corporate Counsel
Kenneth Martindale, Pres and CEO of Rite Aid Stores
Derek Griffith, Executive Vice President - Store Operations
Enio Montini, Executive Vice President - Merchandising
Louis Miramontes, Independent Director
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations
Matthew Schroeder, Chief Financial Officer, Senior Vice President
Robert Knowling, Independent Director
Andre Persaud, Executive Vice President - Retail
Bryan Everett, Executive Vice President - Store Operations
Doug Donley, Chief Accounting Officer, Senior Vice President
John Standley, Chairman, CEO and Chairman of Executive Committee
James Peters, Chief Operating Officer

Stock Performance Indicators

Current Sentiment - RAD

Rite Aid Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Rite Aid. What is your perspective on investing in Rite Aid? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Purchased over 50 shares of
2 days ago
Traded for 39.69
Purchased over 20 shares of
2 days ago
Traded for 79.49
Sold over 20 shares of
2 days ago
Traded for 79.49
Sold over 90 shares of
2 days ago
Traded for 39.69
Sold over 90 shares of
2 days ago
Traded for 79.49
Additionally, take a look at Your Equity Center. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page